Medicare Enrolled
Dr. Anitha Angan, MD
Pulmonary Disease · San Ramon, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Angan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Angan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Angan
Dr. Anitha Angan is a pulmonary disease specialist in San Ramon, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Angan performed 1,480 Medicare services across 828 unique beneficiaries.
Between the years covered by Open Payments, Dr. Angan received a total of $6,926 from 48 pharmaceutical and/or device companies across 395 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Angan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 26% volume in CA
$6,926 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,480
Medicare services
Top 26% in CA for pulmonary disease
828
Unique beneficiaries
$89
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~82 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
377 | $65 | $115 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
272 | $81 | $145 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
191 | $107 | $215 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
138 | $71 | $151 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
95 | $156 | $420 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
93 | $115 | $225 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
78 | $104 | $225 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
58 | $115 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
39 | $149 | $350 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
32 | $188 | $425 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
27 | $9 | $40 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
26 | $11 | $40 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
26 | $8 | $35 |
| Insertion of infusion tube A procedure to place a tube used for delivering infusions in patients aged 5 years or older. |
14 | $80 | $200 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $106 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
0.0% medium
99.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,926
Total received (2018-2024)
Avg $989/year across 7 years
Top 23% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
395
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,675 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$251 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,296
2023
$1,285
2022
$1,184
2021
$1,194
2020
$948
2019
$534
2018
$484
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$219
GlaxoSmithKline, LLC.
$215
Regeneron Healthcare Solutions, Inc.
$199
Boehringer Ingelheim Pharmaceuticals, Inc.
$164
Mylan Specialty L.P.
$147
Amgen Inc.
$141
GENZYME CORPORATION
$56
Medical Device Business Services, Inc.
$37
Exact Sciences Corporation
$31
ABIOMED
$29
Takeda Pharmaceuticals U.S.A., Inc.
$25
Electromed, Inc.
$17
Sumitomo Pharma America, Inc.
$16
Top 3 companies account for 48.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,328
GlaxoSmithKline, LLC.
$1,078
Boehringer Ingelheim Pharmaceuticals, Inc.
$670
Sunovion Pharmaceuticals Inc.
$624
Janssen Pharmaceuticals, Inc
$424
Regeneron Healthcare Solutions, Inc.
$398
Mylan Specialty L.P.
$332
GENZYME CORPORATION
$261
Amgen Inc.
$179
SANOFI-AVENTIS U.S. LLC
$141
Advanced Respiratory, Inc
$116
Novo Nordisk Inc
$102
Sumitomo Pharma America, Inc.
$89
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$77
Philips Electronics North America Corporation
$67
PFIZER INC.
$65
Novartis Pharmaceuticals Corporation
$59
AbbVie Inc.
$51
Allergan, Inc.
$51
Avanir Pharmaceuticals, Inc.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$50
Baxter Healthcare
$50
Nestle HealthCare Nutrition Inc.
$49
ABBVIE INC.
$47
Gilead Sciences, Inc.
$39
Medical Device Business Services, Inc.
$37
Acacia Pharma Inc
$37
Eisai Inc.
$34
Insmed, Inc.
$33
Genentech USA, Inc.
$32
Exact Sciences Corporation
$31
ABIOMED
$29
Actelion Pharmaceuticals US, Inc.
$26
NESTLE HEALTHCARE NUTRITION INC.
$25
EKOS Corporation
$23
VIVUS LLC
$22
Sun Pharmaceutical Industries Inc.
$21
Teva Pharmaceuticals USA, Inc.
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Inogen, Inc.
$18
Paratek Pharmaceuticals, Inc.
$18
Electromed, Inc.
$17
Neurocrine Biosciences, Inc.
$17
Merck Sharp & Dohme LLC
$15
Circassia Pharmaceuticals Inc
$15
Otsuka America Pharmaceutical, Inc.
$14
Mallinckrodt LLC
$14
Astellas Pharma US Inc
$11
Top 3 companies account for 44.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO ELLIPTA · AVYCAZ · AirDuo Digihaler · Arikayce · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BYFAVO · CREON · CUVITRU · Cologuard Collection Kit · DIFICID · DUAKLIR PRESSAIR · DUPIXENT · Dayvigo · EKOSONIC · ELIQUIS · ENTRESTO · EZALLOR SPRINKLE · Esbriet · FARXIGA · FASENRA · GEMTESA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INGREZZA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Impella · JARDIANCE · KAPSPARGO · KRYSTEXXA · LOKELMA · LONHALA MAGNAIR · MYRBETRIQ · Monarch · NUCALA · NUEDEXTA · NUZYRA · Nuedexta · OFEV · OPSUMIT · Ozempic · PANCREAZE · Rybelsus · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · UBRELVY · UTIBRON · UTIBRON NEOHALER · Utibron · Veklury · Wegovy · XARELTO · XIFAXAN · XOLAIR · Xolair · YUPELRI · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
66
Per 100K population
5.7
County median income
$125,727
Nearest hospital
SAN RAMON REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Angan is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Angan experienced with nursing facility visit, low complexity?
Based on Medicare claims data, Dr. Angan performed 377 nursing facility visit, low complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Angan receive payments from pharmaceutical companies?
Yes. Dr. Angan received a total of $6,926 from 48 companies across 395 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Angan's costs compare to other pulmonary diseases in San Ramon?
Dr. Angan's average Medicare payment per service is $89. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Angan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in San Ramon
Browse pulmonary diseases in San Ramon ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology